Bioventus (BVS) FCF Margin Growth (3y) (2023 - 2026)
Bioventus (BVS) FCF Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.88 Bn | 176.59 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 108.68 Bn | 99.46 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 68.54 Bn | 67.09 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 48.26 Bn | 44.58 Bn | 1.29 Bn | -2,196.00 |
| 6 | Dexcom | 28.39 Bn | 27.28 Bn | 750.30 Mn | 2,679.00 |
| 7 | GE HealthCare Technologies | 28.22 Bn | 25.93 Bn | 1.98 Bn | -472.00 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn | -20.00 |
| 10 | Bioventus | 826.57 Mn | 790.72 Mn | 90.77 Mn | 544.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 544.00 |
| Dec 31, 2025 | 1,525.00 |
| Sep 27, 2025 | 2,158.00 |
| Jun 28, 2025 | 1,940.00 |
| Mar 29, 2025 | 171.00 |
| Dec 31, 2024 | 880.00 |
| Sep 28, 2024 | 132.00 |
| Jun 29, 2024 | -521.00 |
| Mar 30, 2024 | 1,739.00 |
| Dec 31, 2023 | -2,018.00 |
| Sep 30, 2023 | -3,052.00 |
| Jul 1, 2023 | -420.00 |
| Apr 1, 2023 | -2,119.00 |